Press Enter to Main Content
您的瀏覽器似乎不支援JavaScript語法,但沒關係,這裡的JavaScript語法並不會影響到內容的陳述, 如需要選擇字級大小,IE6請利用鍵盤按住ALT鍵+ V → X → (G)最大(L)較大(M)中(S)較小(A)小,來選擇適合您的文字大小, 而IE7或Firefox瀏覽器則可利用鍵盤 Ctrl + (+)放大(-)縮小來改變字型大小,如需要回到上一頁可使用瀏覽器提供的 Alt+左方向鍵(←) 快速鍵功能,列印可使用瀏覽器提供的(Ctrl+P)功能。
  • facebook
  • line
  • twitter
  • Print
  • Back

Taiwan Food and Drug Administration Held 2018 Taiwan-ASEAN Symposium

  • Data Source:Food and Drug Administration, Ministry of Health and Welfare
  • Created:2018-09-05
  • Last Updated:2018-09-05

Taiwan Food and Drug Administration of the Ministry of Health and Welfare (TFDA) will hold “2018 Taiwan-ASEAN Drug Regulatory Symposium” in Taipei, Taiwan from 3rd to 6th September this year. The theme of the symposium is management strategy of innovative drugs such as biologics, biosimilars and vaccines. The purpose of the conference, based on the New Southbound Policy, is to strengthen communication between Taiwan and ASEAN countries, and to help Taiwan pharmaceutical industries receive the latest drug information from ASEAN countries. A former manager of US Center for Disease Control and Prevention (US CDC) and representatives of Thailand, Malaysia, Indonesia, the Philippines, and Vietnam health authorities will attend the meeting to share with their medicine management strategies.

Following the format of the first symposium in 2017, events scheduled will include: face-to-face workshop, public seminar, and site visiting for the research and analysis laboratory of TFDA and the domestic pharmaceutical industries. TFDA and the representatives from the industry will share Taiwan’s current drug regulations and the development of biomedicine in these workshops. ASEAN representatives will explain their domestic drug regulatory policy in the public seminar.

TFDA hopes to enhance the communication between ASEAN countries and increase the opportunity for cooperation with the international community.